Capricor Therapeutics, Inc. (CAPR)
NASDAQ: CAPR · Real-Time Price · USD
9.99
-0.06 (-0.60%)
Jun 26, 2025, 12:11 PM - Market open
Capricor Therapeutics Stock Forecast
Stock Price Forecast
The 7 analysts that cover Capricor Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $35.57, which forecasts a 256.06% increase in the stock price over the next year. The lowest target is $22 and the highest is $77.
Price Target: $35.57 (+256.06%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Capricor Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jones Trading | Jones Trading | Strong Buy Maintains $40 → $29 | Strong Buy | Maintains | $40 → $29 | +190.29% | Jun 25, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $77 | Strong Buy | Reiterates | $77 | +670.77% | Jun 24, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $43 → $22 | Buy | Maintains | $43 → $22 | +120.22% | Jun 23, 2025 |
| Roth Capital | Roth Capital | Strong Buy Reiterates $31 | Strong Buy | Reiterates | $31 | +210.31% | Jun 17, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $77 | Strong Buy | Reiterates | $77 | +670.77% | Jun 13, 2025 |
Financial Forecast
Revenue This Year
79.94M
from 22.27M
Increased by 258.96%
Revenue Next Year
86.36M
from 79.94M
Increased by 8.02%
EPS This Year
-0.42
from -1.15
EPS Next Year
-0.43
from -0.42
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 244.1M | 190.6M | 275.4M | ||
| Avg | 79.9M | 86.4M | 180.0M | ||
| Low | 5.9M | 25.4M | 66.2M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 996.2% | 138.4% | 218.9% | ||
| Avg | 259.0% | 8.0% | 108.5% | ||
| Low | -73.6% | -68.2% | -23.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.80 | 1.28 | 2.09 | ||
| Avg | -0.42 | -0.43 | 1.21 | ||
| Low | -1.87 | -1.33 | -0.48 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.